1Korth C, May BC, Cohen FE, et al . Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease[J]. Proc-Natl-Acad-Sci-U-S-A ,2001,98(17) :9836.
2Cooper FA. Quinacrine in possible or probable CJD: it is blinded investigators, not patients, who must be in equipoise over treatment [ J ].BMJ,2002,324(7331 ) :239.
3Satoh K, Shirabe S, Eguchi K, et al . Toxicity of quinacrine can be reduced by co-administration of P-glycoprotein inhibitor in sporadic Creutzfeldt-Jakob disease[J]. Cell Mol Neurobiol ,2004,24(6) :873.
4Gayrard V, Pieard HN, Viguie C, et al . A possible pharmacological explanation for quinacrine failure to treat priori diseases: pharmacokinetic investigations in a ovine model d scrapie[J]. Br J Pharmacol ,2005,144(3 ) :386.
5Eckart WU, Vondra H Malaria and World War Ⅱ: German malaria experiments 1939-45[J]. Parassitologia ,2000,42(1-2) :53.
6Hays CW. The United States Army and malaria control in World War Ⅱ[J]. Paroasitologia ,2000,42(1-2) :47.
7Chauhan PM, Srivastava SK, Present trends and future strategy in chemotherapy of malaria[J]. Curr-Med-Chem ,2001,8(13) : 1535.
